Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
MAYNE PHARMA
{{company.company_channel.channel_name}}
Media Room
Latest
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
NEXTSTELLIS® oral contraceptive has been nominated for the 2022 prix galien usa award for best pharmaceutical agent
2022-08-02 13:00
MAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS® AND EXPAND ACCESS TO BIRTH CONTROL
2022-07-29 13:00
Mayne Pharma and Mithra Announce TGA Approval of NEXTSTELLIS® Oral Contraceptive
2021-11-30 09:18
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
2021-09-21 22:00
Mayne Pharma launches another generic oral contraceptive
2021-03-05 05:34
New Data On Mayne Pharma's Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020
2020-10-26 12:10
Mayne Pharma Launches Chlorzoxazone Tablet in the United States
2020-07-28 12:02
Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US
2020-06-24 12:10
Toni Nesci Named Head of Mayne Contract Services and New Website Launched
2020-06-03 10:39
Mayne Pharma Executes 20 Year License and Supply Agreement for Novel Oral Contraceptive in Australia
2020-05-28 17:23
Mayne Pharma launches BAC 300 capsules in the United States
2020-05-22 13:44
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
2020-04-16 12:30
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US
2019-10-02 12:01
FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis
2019-05-22 18:00
FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%
2019-04-30 22:35
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States
2019-02-13 20:30
TOLSURA (TM) (SUBA®-itraconazole) Antifungal Capsule Now Available in the United States
2019-01-30 20:30
Mayne Pharma receives FDA approval of Tolsura™ (SUBA®-itraconazole capsules) for the treatment of certain fungal infections
2018-12-12 07:05
Metrics Contract Services Announces Serialization Capabilities at Greenville Site
2018-11-13 04:29
Metrics Contract Services Adds Commercial Gerteis Roller Compaction Capabilities
2018-11-01 20:00
1
2